相关实验视频
Updated: Jul 11, 2026

10:42
A Tripeptide-Stabilized Nanoemulsion of Oleic Acid
Published on: February 27, 2019
9.4K
通过新的纳米乳液配方增强Callistemon citrinus (Curtis) 精油的生物活性
Hamta Haghbayan1, Roya Moghimi1, Yaghoub Sarrafi1
1Department of Organic Chemistry, Faculty of Chemistry, University of Mazandaran, Babolsar, Iran.
Journal of biomaterials science. Polymer edition
|August 5, 2024
概括
这项研究开发了一个稳定的纳米乳液 (NE) 从Callistemon citrinus精油 (EO). 优化的NE显示出增强的抗菌,抗真菌和杀性质,显示出作为天然杀虫剂的巨大潜力.
科学领域:
- * 制药科学 制药科学
- * 农业化学 农业化学
- * 材料科学 材料科学
背景情况:
- * 精油 (EOs) 是具有潜在生物活性的天然产品,但往往缺乏稳定性和生物利用性.
- *纳米乳液 (NEs) 提供了一个有前途的输送系统,以提高EO的有效性和稳定性.
- *Callistemon citrinus精油 (EO) 已经证明了各种生物活性,需要有效的配方来实现实际应用.
研究的目的:
- * 用Callistemon citrinus精油 (EO) 制备和优化一个稳定的纳米乳液 (NE).
- * 评估开发的NE的物理化学特性和稳定性.
- * 评估优化NE与纯EO相比的抗微生物 (抗菌,抗真菌) 和杀性活动.
主要方法:
- *优化NE配方参数,包括油度,表面活性剂 (Tween 80) 度和超声波时间.
- *NE的物理化学表征,包括粒子大小分析和红外光谱检测以确认封装.
- *在6个月内对NE进行加速稳定性测试.
- * 确定抗菌和抗真菌试验的最小抑制度 (MIC).
- *针对Chilo suppressalis (步行者) 幼虫的杀性测定.
主要成果:
- *成功开发了一种稳定的纳米乳液 (B10),颗粒大小为33.15±0.32nm.
- * 红外光谱学证实了在NE内成功封装Callistemon citrinus EO.
- *优化的NE (B10) 在六个月内表现出了显著的稳定性.
- * B10 显示显著增强了对 Fusarium oxysporum 和 Escherichia coli 的抗菌活性 (50 倍更有效) (MIC 0.256 mg/mL 与 EO 的 4 mg/mL 相比).
- *NE配方 (B10) 在48小时内实现了95.2%的幼虫死亡率对抗Chilo suppressalis.
结论:
- *开发的Callistemon citrinus纳米乳液 (B10) 是稳定且高效的.
- *NE配方显著提高了精油的抗微生物和杀效果.
- *Callistemon citrinus NE作为一种强大而稳定的天然杀菌剂和杀虫剂显示出相当大的前景.
相关概念视频
Bioavailability Enhancement: Determination and Conceptual Approaches in Overcoming Bioavailability Problems
Bioavailability is a critical pharmacological concept that measures the extent and rate at which an active drug ingredient or therapeutic moiety enters the systemic circulation, remaining unchanged. It's a pivotal factor in determining a drug's efficacy and safety.The Biopharmaceutics Classification System (BCS) plays an essential role in drug development by categorizing drugs into four classes based on their solubility and permeability. This classification aids in understanding drug absorption...
Bioavailability Enhancement: Drug Solubility Enhancement
Bioavailability is a critical factor in determining a drug's effectiveness. It refers to the proportion of a drug that enters the circulation when introduced into the body and is, as a result, able to have an active effect. Enhancing bioavailability is essential for drugs with poor solubility, as it can significantly impact their therapeutic efficacy. Various methods are employed to increase the solubility of drugs, thereby enhancing their bioavailability.Micronization and nanonization are...
Bioavailability Enhancement: Drug Permeability Enhancement
After oral administration, poor permeability often limits the rate at which drugs are absorbed through the intestinal epithelium. Enhancing drug permeability is crucial for effective therapy, and several strategies have been developed to overcome this challenge.One effective strategy involves the use of lipid-based formulations. These formulations enhance dissolution and solubility, targeting physiological mechanisms to increase drug absorption. This includes stimulating bile salt secretion,...
Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
Improving a drug's stability in the gastrointestinal (GI) tract is paramount for enhancing its bioavailability and therapeutic effectiveness. Various strategies are employed to protect the drug from the harsh gastric milieu and to ensure its release and absorption at the desired site within the GI tract.Polymer coatings are one such method used to shield drugs from the stomach's acidic environment. By preventing premature drug release, these coatings improve the bioavailability of unstable...

